Overview
The purpose of this study is to evaluate point of care SARS-Cov2 Virus IgG/IgM rapid test cassette Clungene test and correlate it with the standard method of testing in inpatients who have tested positive or negative for COVID19.
Description
This is a laboratory testing study using the SARS-Cov2 Virus IgG/IgM rapid test cassette Clungene test to determine the presence of IgM and IgG antibodies in subjects who have tested negative or positive for COVID-19. The study is observational and subjects will be assigned to one of two arms depending on the results of their nCOVID-19 test.
Eligibility
Inclusion Criteria:
- Received confirmed COVID-19 positive or negative test from Sharp HealthCare's standard method of testing.
- Age >/=18 years old.
- Access to a phone in the hospital room or an electronic device that is capable of receiving phone calls and/or video calls and/or e-mail.
- Able to read/write/speak English or Spanish fluently.
- Subjects must have the ability to understand the requirements of the study, provide informed consent, and provide authorization of use and disclosure of personal health information.
- Hospitalized at the time of consent or recently discharged with leftover blood stored at hospital laboratory
Exclusion Criteria:
- Impaired cognitive or decision-making capacity (based on the clinical judgment of the PI or designee)